Search Results - "DeBlasio, Richelle N."

Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients by Davar, Diwakar, Dzutsev, Amiran K, McCulloch, John A, Rodrigues, Richard R, Chauvin, Joe-Marc, Morrison, Robert M, Deblasio, Richelle N, Menna, Carmine, Ding, Quanquan, Pagliano, Ornella, Zidi, Bochra, Zhang, Shuowen, Badger, Jonathan H, Vetizou, Marie, Cole, Alicia M, Fernandes, Miriam R, Prescott, Stephanie, Costa, Raquel G F, Balaji, Ascharya K, Morgun, Andrey, Vujkovic-Cvijin, Ivan, Wang, Hong, Borhani, Amir A, Schwartz, Marc B, Dubner, Howard M, Ernst, Scarlett J, Rose, Amy, Najjar, Yana G, Belkaid, Yasmine, Kirkwood, John M, Trinchieri, Giorgio, Zarour, Hassane M

“…Anti-programmed cell death protein 1 (PD-1) therapy provides long-term clinical benefits to patients with advanced melanoma. The composition of the gut…”
Get full text

Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1 by McCulloch, John A., Davar, Diwakar, Rodrigues, Richard R., Badger, Jonathan H., Fang, Jennifer R., Cole, Alicia M., Balaji, Ascharya K., Vetizou, Marie, Prescott, Stephanie M., Fernandes, Miriam R., Costa, Raquel G. F., Yuan, Wuxing, Salcedo, Rosalba, Bahadiroglu, Erol, Roy, Soumen, DeBlasio, Richelle N., Morrison, Robert M., Chauvin, Joe-Marc, Ding, Quanquan, Zidi, Bochra, Lowin, Ava, Chakka, Saranya, Gao, Wentao, Pagliano, Ornella, Ernst, Scarlett J., Rose, Amy, Newman, Nolan K., Morgun, Andrey, Zarour, Hassane M., Trinchieri, Giorgio, Dzutsev, Amiran K.

“…Ample evidence indicates that the gut microbiome is a tumor-extrinsic factor associated with antitumor response to anti-programmed cell death protein-1 (PD-1)…”
Get full text

The Combined Roles of Race/Ethnicity and Substance Use in Predicting Likelihood of Kidney Transplantation by DeBlasio, Richelle N., Myaskovsky, Larissa, DiMartini, Andrea F., Croswell, Emilee, Posluszny, Donna M., Puttarajappa, Chethan, Switzer, Galen E., Shapiro, Ron, DeVito Dabbs, Annette J., Tevar, Amit D., Hariharan, Sundaram, Dew, Mary Amanda

“…Racial/ethnic minorities face known disparities in likelihood of kidney transplantation. These disparities may be exacerbated when coupled with ongoing…”
Get full text

The Combined Roles of Race/Ethnicity and Substance Use in Predicting Likelihood of Kidney Transplantation by DeBlasio, Richelle N., Myaskovsky, Larissa, DiMartini, Andrea F., Croswell, Emilee, Posluszny, Donna M., Puttarajappa, Chethan, Switzer, Galen E., Shapiro, Ron, DeVito Dabbs, Annette J., Tevar, Amit D., Hariharan, Sundaram, Dew, Mary Amanda

Get full text

Abstract LB062: Efficacy of Responder-derived Fecal Microbiota Transplant (R-FMT) and Pembrolizumab in Anti-PD-1 Refractory Patients with Advanced Melanoma by Davar, Diwakar, Dzutsev, Amiran, McCulloch, John A., Rodrigues, Richard R., Chauvin, Joe-Marc, Morrison, Robert M., Deblasio, Richelle N., Menna, Carmine, Ding, Quanquan, Pagliano, Ornella, Zidi, Bochra, Zhang, Shuowen, Badger, Jonathan H., Vetizou, Marie, Cole, Alicia M., Fernandes, Miriam R., Prescott, Stephanie, Costa, Raquel G., Balaji, Ascharya K., Morgun, Andrey, Vujkovic-Cvijin, Ivan, Wang, Hong, Borhani, Amir A., Schwartz, Marc B., Dubner, Howard M., Ernst, Scarlett J., Rose, Amy, Najjar, Yana G., Belkaid, Yasmine, Kirkwood, John M., Trinchieri, Giorgio, Zarour, Hassane M.

“…Background: Monoclonal antibodies (mAb) targeting the programmed cell death protein 1 (PD-1) receptor provide durable long-term benefit in a subset of patients…”
Get full text